ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Wednesday, 18 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Acquisition

Piramal Pharma Acquisition

Piramal Pharma exercised a call option to acquire the remaining 26% stake in subsidiary Yapan Bio. Final consideration and transfer date are yet to be finalised.

Source

BSE filing, NSE: PPLPHARMA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Piramal Pharma Ltd: key numbers

Share price
₹242.61
Market cap
₹32,300 Cr
Revenue (annual)
₹8,869 Cr
Net profit (annual)
₹-325.9 Cr
P/E (TTM)
-154.7×Sector 48.6×
Promoter holding
34.80%+0.00% QoQ
FII holding
13.65%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Piramal Pharma Ltd

All →

Other acquisition announcements

All →